Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health

By F. He, G. Macgregor. Journal of Human Hypertension, 2002

811 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Nutrition and Dietetics, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/eefad96ca59e94ef7a5f9dc0f446fc1df789d37e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. I. Graham
2. G. MacGregor
3. T. Ivanova
4. F. He
5. M. Ezzati
6. D. Mozaffarian

In Nutrition and Dietetics

1. D. Mozaffarian
2. I. Graham
3. G. MacGregor
4. T. Ivanova
5. M. Ezzati
6. F. He

In Public Health, Environmental and Occupational Health

1. D. Mozaffarian
2. I. Graham
3. G. MacGregor
4. T. Ivanova
5. F. He
6. M. Ezzati
7. G. Danaei

Citations in the corpus

• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, neutral): “6 mmHg in normotensive patients.(284) The DASH trial showed a dose–response relationship between sodium reduction and BP reduction.”
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “6 mmHg in normotensive patients.(317) The Dietary Approaches to Stop Hypertension (DASH) trial showed a dose–response relation between sodium reduction and BP reduction.”
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice. (2016, background): “6 mmHg in normotensive patients.(317) The Dietary Approaches to Stop Hypertension (DASH) trial showed a dose–response relation between sodium reduction and BP reduction.”
• Reducing population salt intake worldwide: from evidence to implementation. (2010, methodology): “However, randomized trials of longer term modest salt reduction showed no significant changes in total cholesterol, triglyceride, or low- or high-density lipoprotein cholesterol.(43) A number of studies have looked at the effects of changing salt intake on glucose tolerance and insulin sensitivity.”
• Guidelines on cardiovascular disease prevention in clinical practice: the European perspective (2005, positive): “6 mmHg in normotensive patients.(318) The 1930 Dietary Approaches to Stop Hypertension (DASH) trial showed a dose–response relation 1931 between sodium reduction and BP reduction.”
• The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors (2009, result): “Mortality effects of dietary salt were sensitive to the magnitude of its effects on SBP, because there was an almost 2-fold difference between two separate meta-analyses of salt reduction trials [37,38].”